ciprofloxacin and Recrudescence studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

Excerpt	Relevance	Reference
"This study was designed to compare the efficacy of ciprofloxacin plus rifampin (CR) and ciprofloxacin plus doxycycline (CD) versus doxycycline plus rifampin (DR) in the treatment of brucellosis."	9.14	A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis. ( Hashemi, SH; Keramat, F; Mamani, M; Ranjbar, M; Zeraati, F, 2009)
"To evaluate, in a prospective, open-label study, the influence of antibiotics and azathioprine on the clinical outcome of perianal fistulas in patients with Crohn's disease."	9.10	Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. ( Dejaco, C; Harrer, M; Miehsler, W; Reinisch, W; Vogelsang, H; Waldhoer, T, 2003)
"Ciprofloxacin 500 mg orally twice daily was compared to pivampicillin 700 mg orally twice daily for 10 days in 172 men (41-85 years) with acute epididymitis."	9.09	[Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years]. ( Eickhoff, JH; Frimodt-Møller, C; Frimodt-Møller, N; Walter, S, 2000)
"To evaluate the costs, consequences, effectiveness, and safety of ciprofloxacin vs standard antibiotic care in patients with an initial acute exacerbation of chronic bronchitis (AECB) as well as recurrent AECBs over a 1-year period."	9.08	A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. ( Cook, R; Eastwood, C; Grossman, R; LaForge, J; Lampron, N; Mukherjee, J; Vaughan, D, 1998)
"We evaluated and compared the efficacy of post-intercourse and daily oral ciprofloxacin prophylaxis against recurrent lower urinary tract infections in 135 sexually active premenopausal women."	9.08	Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. ( Asbach, HW; Gerharz, E; Melekos, MD; Naber, KG; Weingaertner, K; Zarakovitis, IE, 1997)
"A prospective, randomised trial was undertaken to compare the efficacy of ciprofloxacin and netilmicin for the treatment of acute pyelonephritis."	9.07	Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. ( Bailey, RR; Lynn, KL; Peddie, BA; Robson, RA; Smith, A, 1992)
"The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections."	9.07	A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992)
"Two single-dose regimens of ciprofloxacin, 100 and 250 mg, were compared in the treatment of uncomplicated urinary tract infections in women."	9.06	Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. ( Flepp, M; Garlando, F; Lüthy, R; Meier, B; Rietiker, S; Täuber, MG, 1987)
"The Infectious Diseases Society of America guidelines recommend either 14 days of trimethoprim-sulfamethoxazole (TMP-SMX) or 7 days of ciprofloxacin for the treatment of pyelonephritis."	7.85	A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis. ( Conley, AT; Fox, MT; Melia, MT; Same, RG; Tamma, PD, 2017)
"In a relapsed case of brucellosis after short-term antibiotic therapy using doxycycline and ciprofloxacin two Brucella strains were isolated, before and after treatment."	7.73	Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. ( Al Dahouk, S; Hagen, RM; Neubauer, H; Nockler, K; Scholz, HC; Tomaso, H; Vergnaud, G; Wittig, M, 2005)
"Fifty-five human immunodeficiency virus-infected patients with Salmonella bacteremia were studied to assess the rate of and causes for recurrence and to determine the influence on relapse of zidovudine, cotrimoxazole, and antimicrobial suppressive therapy according to the susceptibility of the isolates."	7.70	Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. ( Calderon, C; Casado, JL; Frutos, B; Guerrero, A; Martinez-Beltran, J; Navas, E; Valdezate, S, 1999)
"This report describes a relapse of Salmonella paratyphi B infection in a child with biliary atresia, following 2 weeks of treatment with ciprofloxacin."	7.69	A relapse of paratyphoid fever after treatment with ciprofloxacin in a child with congenital biliary atresia. ( Eltringham, IJ; Ireland, D; Irish, D; Issler, H; Teall, A; Thalange, N, 1997)
"Eighteen children with bacteriologically confirmed severe typhoid fever were initially treated intravenously with ciprofloxacin (10 mg/kg of body weight per day)."	7.68	Ciprofloxacin for treatment of severe typhoid fever in children. ( Bhattacharya, MK; Bhattacharya, SK; Dutta, P; Lahiri, M; Mitra, U; Rasaily, R; Saha, MR, 1993)
"Fifty patients with gram-negative lower respiratory tract infections were treated with intravenous ciprofloxacin to evaluate efficacy and safety."	7.67	Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication. ( Cumbo, TJ; Nix, DE; Peloquin, CA; Sands, MF; Schentag, JJ, 1989)
"Eighty-three patients with serious urinary tract infections were treated with oral ciprofloxacin."	7.67	Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. ( Fass, RJ, 1987)
"Two developed recurrence of paratyphoid fever, 17 days and 4 months after therapy."	6.67	Short course ciprofloxacin therapy for enteric fever. ( Jesudason, MV; John, J; Kaur, A; Keystone, JS; Kozarsky, PE; Kudva, GC; Lalitha, MK; Mathai, D; Pulimood, BM; Thomas, M, 1993)
"The epidemiology of typhoid fever in South Asia has changed."	5.48	Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. ( Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B, 2018)
" The higher dosage showed a reduced amount of reinfections and relapses (19% and 16% versus 5% and 0%)."	5.28	Two different dosages of ciprofloxacin in patients with respiratory tract infections. ( Brutel de la Rivière, T; Daniëls-Bosman, MS; ten Velde, GP, 1989)
"This study was designed to compare the efficacy of ciprofloxacin plus rifampin (CR) and ciprofloxacin plus doxycycline (CD) versus doxycycline plus rifampin (DR) in the treatment of brucellosis."	5.14	A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis. ( Hashemi, SH; Keramat, F; Mamani, M; Ranjbar, M; Zeraati, F, 2009)
"Patients with pouchitis at least twice in the previous year or requiring continuous antibiotics, associated with a pouchitis disease activity index (PDAI) > or =7 (0 = perfect; 18 = worst), in whom remission was induced by four weeks of combined metronidazole and ciprofloxacin, were randomised to receive VSL#3 6 g or placebo once daily for one year or until relapse."	5.11	Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. ( Campieri, M; Gionchetti, P; Helwig, U; Kamm, MA; Mimura, T; Nicholls, RJ; Poggioli, G; Rizzello, F; Schreiber, S; Talbot, IC, 2004)
"To evaluate, in a prospective, open-label study, the influence of antibiotics and azathioprine on the clinical outcome of perianal fistulas in patients with Crohn's disease."	5.10	Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. ( Dejaco, C; Harrer, M; Miehsler, W; Reinisch, W; Vogelsang, H; Waldhoer, T, 2003)
"To compare 1 week of trimethoprim-sulfamethoxazole treatment and 1 week of ciprofloxacin treatment in HIV-infected patients with chronic diarrhea caused by I."	5.09	Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. ( Fitzgerald, DW; Johnson, WD; Pape, JW; Verdier, RI, 2000)
"Ciprofloxacin 500 mg orally twice daily was compared to pivampicillin 700 mg orally twice daily for 10 days in 172 men (41-85 years) with acute epididymitis."	5.09	[Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years]. ( Eickhoff, JH; Frimodt-Møller, C; Frimodt-Møller, N; Walter, S, 2000)
"To evaluate the costs, consequences, effectiveness, and safety of ciprofloxacin vs standard antibiotic care in patients with an initial acute exacerbation of chronic bronchitis (AECB) as well as recurrent AECBs over a 1-year period."	5.08	A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. ( Cook, R; Eastwood, C; Grossman, R; LaForge, J; Lampron, N; Mukherjee, J; Vaughan, D, 1998)
"We evaluated and compared the efficacy of post-intercourse and daily oral ciprofloxacin prophylaxis against recurrent lower urinary tract infections in 135 sexually active premenopausal women."	5.08	Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. ( Asbach, HW; Gerharz, E; Melekos, MD; Naber, KG; Weingaertner, K; Zarakovitis, IE, 1997)
"A prospective, randomised trial was undertaken to compare the efficacy of ciprofloxacin and netilmicin for the treatment of acute pyelonephritis."	5.07	Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. ( Bailey, RR; Lynn, KL; Peddie, BA; Robson, RA; Smith, A, 1992)
"The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections."	5.07	A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992)
"Two single-dose regimens of ciprofloxacin, 100 and 250 mg, were compared in the treatment of uncomplicated urinary tract infections in women."	5.06	Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. ( Flepp, M; Garlando, F; Lüthy, R; Meier, B; Rietiker, S; Täuber, MG, 1987)
"We describe a patient with ulceroglandular tularemia who initially responded to therapy with gentamicin but then clinically relapsed."	4.79	Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. ( Pombo, DJ; Risi, GF, 1995)
"The Infectious Diseases Society of America guidelines recommend either 14 days of trimethoprim-sulfamethoxazole (TMP-SMX) or 7 days of ciprofloxacin for the treatment of pyelonephritis."	3.85	A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis. ( Conley, AT; Fox, MT; Melia, MT; Same, RG; Tamma, PD, 2017)
" However, although a single treatment of chitosan followed by ciprofloxacin administration had a marked effect on reducing UPEC titers within the bladder, this treatment failed to prevent relapsing bacteriuria."	3.85	Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders. ( Blango, MG; Erman, A; Hergouth, VK; Kos, MK; Mulvey, MA; Veranic, P, 2017)
"The concept that the gut microbiota plays a major role in the development of pouchitis in ulcerative colitis patients after restorative proctocolectomy with ileal pouch-anal anastomosis, is widely accepted and supported by a widespread use of some antibiotics (metronidazole and/or ciprofloxacin, rifaximin) to treat this condition."	3.80	Role of probiotics in the management of pouchitis. ( Guslandi, M, 2014)
"We report a case of recurrent, multifocal Salmonella enterica serotype Paratyphi A breast abscesses, resistant to ciprofloxacin, which relapsed despite surgery, aspiration and multiple courses of antibiotics, including co-trimoxazole and azithromycin."	3.78	Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A. ( Fernando, S; Gottlieb, T; Molland, JG, 2012)
"In the light of current concerns regarding ciprofloxacin resistance and the changing face of malignant otitis externa, we reviewed cases of malignant otitis externa treated in our centre, in order both to evaluate the current epidemiology of the condition and to assess the status of drug resistance in our patient population."	3.76	Malignant otitis externa: case series. ( Ali, T; Anari, S; ElBadawey, MR; Meade, K; Zammit-Maempel, I, 2010)
"As typhoid fever was suspected and finally confirmed, the patient was treated with oral ciprofloxacin for 14 days."	3.74	[Acute myocarditis after visiting Pakistan]. ( Kohler, BM; Türoff, A; Vollnberg, H, 2008)
"In a relapsed case of brucellosis after short-term antibiotic therapy using doxycycline and ciprofloxacin two Brucella strains were isolated, before and after treatment."	3.73	Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. ( Al Dahouk, S; Hagen, RM; Neubauer, H; Nockler, K; Scholz, HC; Tomaso, H; Vergnaud, G; Wittig, M, 2005)
"We present a case of recurrent infection (infective spondilitis, psoas abscess, and bacteraemia) caused by a single strain of cefotaxime- and ciprofloxacin-resistant and bla(CMY-2)-containing Salmonella enterica serotype choleraesuis during a 4-month period in a patient with uremia."	3.73	Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem. ( Guo, SM; Hsueh, PR; Jean, SS; Lee, YT, 2005)
" The patient was asymptomatic for a month, but the abscess reactivated and was treated with Vancomycin and Ciprofloxacin administered intravenously."	3.72	[Recurrence of bacterial endophthalmitis after penetrating keratoplasty]. ( Domínguez, I; García Serrano, JL; Serrano Laborda, D, 2004)
"Fifty-five human immunodeficiency virus-infected patients with Salmonella bacteremia were studied to assess the rate of and causes for recurrence and to determine the influence on relapse of zidovudine, cotrimoxazole, and antimicrobial suppressive therapy according to the susceptibility of the isolates."	3.70	Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. ( Calderon, C; Casado, JL; Frutos, B; Guerrero, A; Martinez-Beltran, J; Navas, E; Valdezate, S, 1999)
"This report describes a relapse of Salmonella paratyphi B infection in a child with biliary atresia, following 2 weeks of treatment with ciprofloxacin."	3.69	A relapse of paratyphoid fever after treatment with ciprofloxacin in a child with congenital biliary atresia. ( Eltringham, IJ; Ireland, D; Irish, D; Issler, H; Teall, A; Thalange, N, 1997)
"Eighteen children with bacteriologically confirmed severe typhoid fever were initially treated intravenously with ciprofloxacin (10 mg/kg of body weight per day)."	3.68	Ciprofloxacin for treatment of severe typhoid fever in children. ( Bhattacharya, MK; Bhattacharya, SK; Dutta, P; Lahiri, M; Mitra, U; Rasaily, R; Saha, MR, 1993)
"This study was designed to retrospectively review the experience in this center with oral ciprofloxacin 500 mg bid and ip vancomycin 25 mg/L in the treatment of CAPD-related exit site infections and to determine the relationship between exit site infections and peritonitis."	3.68	Relationship between peritonitis and exit site infections in CAPD. ( Bailie, GR; Eisele, G; Lomaestro, B, 1992)
"The effectiveness of treatment of human brucellosis caused by Brucella melitensis with ciprofloxacin alone was investigated in a prospective nonrandomized study."	3.68	Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. ( al-Sibai, MB; el-Shaker, MM; Halim, MA; Khan, BA; Qadri, SM, 1992)
"Fifty patients with gram-negative lower respiratory tract infections were treated with intravenous ciprofloxacin to evaluate efficacy and safety."	3.67	Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication. ( Cumbo, TJ; Nix, DE; Peloquin, CA; Sands, MF; Schentag, JJ, 1989)
"Ciprofloxacin in a low dosage of 250 mg twice a day was applied in the treatment of bacterial infections of the skin."	3.67	[The effectiveness of ciprofloxacin in bacterial skin infections]. ( Blenk, H; Meisel, C, 1988)
"Eighty-three patients with serious urinary tract infections were treated with oral ciprofloxacin."	3.67	Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. ( Fass, RJ, 1987)
"Typhoid and paratyphoid (enteric fever) are febrile bacterial illnesses common in many low- and middle-income countries."	2.82	Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. ( Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N, 2022)
"Of these 22, only 1 patient (5%) had recurrence of acute appendicitis during follow-up."	2.80	Nonoperative treatment with antibiotics versus surgery for acute nonperforated appendicitis in children: a pilot randomized controlled trial. ( Almström, M; Eaton, S; Hall, NJ; Naji, H; Patkova, B; Pierro, A; Svensson, JF; Wester, T, 2015)
"Eleven patients with moderate to active Crohn's disease were enrolled in this trial to receive either L."	2.71	Lactobacillus GG in inducing and maintaining remission of Crohn's disease. ( Herfarth, HH; Rath, HC; Sartor, RB; Schultz, M; Timmer, A; Vanderhoof, JA, 2004)
" In 4 patients, treatment was discontinued prematurely after an adverse event."	2.68	Multicenter study of the efficacy and safety of oral ciprofloxacin in the treatment of chronic suppurative otitis media in adults. The French Study Group. ( Gehanno, P, 1997)
"Three studies were undertaken to determine the minimum effective dosing regimen of ciprofloxacin for the treatment of acute, symptomatic, uncomplicated lower urinary tract infection."	2.68	Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. ( Gallis, HA; Heyd, A; Iravani, A; Kowalsky, SF; McCarty, J; Nolen, T; Sikes, DH; Tice, AD; Tosiello, RL; Whalen, EP, 1995)
"Two developed recurrence of paratyphoid fever, 17 days and 4 months after therapy."	2.67	Short course ciprofloxacin therapy for enteric fever. ( Jesudason, MV; John, J; Kaur, A; Keystone, JS; Kozarsky, PE; Kudva, GC; Lalitha, MK; Mathai, D; Pulimood, BM; Thomas, M, 1993)
"Ciprofloxacin was efficacious in complicated urinary tract infection compared with the current standard of parenteral aminoglycoside among catheterized patients with relatively resistant bacteria."	2.67	Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study. ( Brennen, C; DeVine, J; Fang, GD; Hilf, M; Swanson, D; Wagener, M; Yu, VL; Zadecky, L, 1991)
"Malakoplakia is an uncommon inflammatory condition usually affecting the genitourinary tract, which has been associated with infections, tumors, and immunocompromised states."	2.46	Perianal cutaneous malakoplakia in an immunocompetent patient. ( Boushi, LA; Douri, TH; Shawaf, AZ, 2010)
"This article reviews the possible treatments for pouchitis, focusing especially on treatment with probiotics, which seem to be a new and promising alternative to antibiotics."	2.43	[Probiotics--should we change the treatment strategy for pouchitis?]. ( Kjeldsen, J; Klinge, LG, 2006)
"Factors predictive of recurrence are, according to another study, dependence on oxygen therapy, prolonged corticosteroid therapy, smoking, and/or heart disease."	2.41	[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis]. ( Gaillat, J, 2001)
"We sought to describe the risk of recurrence at 1 month after the end of treatment for FUTI due to ESBL-E according to the oral relay therapy used."	1.62	Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study. ( Andriantahina, I; Angoulvant, F; Birgy, A; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; De Pontual, L; Dommergues, MA; Dubos, F; Gajdos, V; Georget, E; Gillet, Y; Grimprel, E; Jung, C; Launay, E; Levy, C; Lignieres, G; Madhi, F; Pinquier, D; Rybak, A; Soussan-Banini, V; Vignaud, O, 2021)
"One reason for CSOM recurrence might be surgery failure."	1.56	Chronic Suppurative Otitis Media: A Case Report. ( Eslami, G; Ghalavand, Z; Kodori, M; Tabriz, MS; Taheri, M; Yazdi, AK; Yazdi, MMK, 2020)
"The efficacy of antibiotic treatment of pouchitis might be attributed to the establishment of an antibiotic-resistant microbiome with low inflammatory potential."	1.56	Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy. ( Bar, N; Dotan, I; Dubinsky, V; Godny, L; Golan, N; Gophna, U; Keizer, D; Rabinowitz, K; Reshef, L; Tulchinsky, H; Yadgar, K; Zonensain, K, 2020)
"Rhinoscleroma is a chronic infectious disease that is endemic in certain poor areas of the world."	1.48	Rhinoscleroma: a chronic infectious disease of poor areas with characteristic histological features - report of a series of six cases. ( Ben Mansour, N; Chbani, L; Efared, B; El Fatemi, H; Gabrielle, AE; Hammas, N, 2018)
"The epidemiology of typhoid fever in South Asia has changed."	1.48	Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. ( Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B, 2018)
"Even following transplantation, recurrence of PSC is seen in approximately one quarter of patients and leads to high rates of graft failure."	1.46	Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation. ( Gow, P; Hey, P; Johnson, P; Lokan, J, 2017)
"Median time to first recurrence was 60 days (range 14-197)."	1.46	Recurrent otorrhea in chronic suppurative otitis media: is biofilm the missing link? ( Bjarnsholt, T; Eickhardt-Sørensen, SR; Homøe, P; Jensen, RG; Johansen, HK, 2017)
"It is extremely rare that the urinary bladder stones cause vesicorectal fistulas."	1.40	Is vesicolithotomy with bladder wash the answer for rectovesical fistula secondary to neglected vesical stone? Complicated presentation but simple management. ( Elnaim, AK; Mohamed, MM, 2014)
"We present a case of an invasive squamous cell carcinoma of the glans penis, which was treated with topical antifungals and corticosteroids for 2 years prior to diagnosis, necessitating partial glansectomy."	1.39	Squamous cell carcinoma of the penis and topical combination corticosteroid products: a cautionary case. ( Aires, D; Blackmon, J; Laarman, R; Rajpara, A, 2013)
"Typhoid fever is a systemic illness which in high-income countries mainly affects travellers."	1.39	Cases of typhoid fever in Copenhagen region: a retrospective study of presentation and relapse. ( Barrett, FC; Johansen, IS; Knudsen, JD, 2013)
"Pouchitis is the most common long-term complication after restorative total proctocolectomy and IPAA for ulcerative colitis."	1.38	The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. ( Funayama, Y; Haneda, S; Ogawa, H; Sasaki, I; Shibata, C; Suzuki, H; Takahashi, K; Watanabe, K, 2012)
"We report a case of postoperative Mycobacterium abscessus infection of the conjunctiva."	1.35	Postoperative Mycobacterium abscessus nodular conjunctivitis. ( Booth, F; Gottlieb, T; Janarthanan, P; Karim, R; McCarthy, S; Merani, R; Orekondy, S, 2008)
"One month later, a recurrence of PUK on the donor button was noted."	1.35	Recurrence of peripheral ulcerative keratitis on the corneoscleral button in a young man treated successfully with oral corticosteroids. ( Bakiah, S; Ibrahim, M; Selvaraja, V; Wahid, WA, 2008)
"A case of septic arthritis caused by Erysipelothrix rhusiopathiae, after an arthroscopically assisted anterior cruciate ligament (ACL) substitution in a non-immunosuppressed patient is described."	1.32	Septic arthritis caused by Erysipelothrix rhusiopathiae infection after arthroscopically assisted anterior cruciate ligament reconstruction. ( Allianatos, PG; Koutsoukou, AD; Tilentzoglou, AC, 2003)
"The medical treatment of acute pouchitis was usually oral metronidazole (250 mg twice daily) for 2 weeks or oral ciprofloxacin (200 mg thrice daily) in patients who could not tolerate metronidazole."	1.32	Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients. ( Ikeuchi, H; Nakamura, M; Nakano, H; Noda, M; Uchino, M; Yamamura, T; Yanagi, H, 2004)
"The originality of our case is the recurrence of the disease on three occasions with the same bacterium isolated on each occasion, with disease remission after antibiotic therapy."	1.31	Neutrophilic eccrine hidradenitis secondary to infection with Serratia marcescens. ( Azoulay-Petit, C; Combemale, P; Dupin, M; Faisant, M; Kanitakis, J, 2000)
"Twelve patients had no recurrence at 3 to 15 months after the study."	1.30	Efficacy of ototopical ciprofloxacin in pediatric patients with otorrhea. ( Hart, MC; Nahata, MC; Wintermeyer, SM, 1997)
"The rate of recurrence and ADR in the NFX group was lower than that in the CP group."	1.30	[Observation of 212 cases of typhoid fever treated with FQNS]. ( Feng, S; Jiang, S; Wang, X, 1997)
"stutszeri (1), and unidentified (1)."	1.29	Treatment and prevention of relapses of CAPD Pseudomonas peritonitis. ( Eftimimiadou, A; Kaliengidou, M; Kartali, S; Panagoutsos, S; Papazoglou, D; Pasadakis, P; Thodis, E; Vargemezis, V, 1993)
"Most of these carriers had typhoid in the preantibiotic era and remain potential sources of disease when they provide meals for others, not uncommonly grandchildren."	1.29	A case of recurrent typhoid fever in the United States: importance of the grandmother connection and the use of large restriction fragment pattern analysis of genomic DNA for strain comparison. ( Barth, SS; Gibson, JL; Steingrube, VA; Wallace, RJ; Wright, PW, 1994)
"Three cases of recrudescence and relapse of Neisseria meningitidis group B meningitis and septicaemia are reported."	1.29	Recrudescence and relapse of meningococcal meningitis and septicaemia. ( Nielsen, PE; Thelle, T; Tvede, M, 1995)
"Episodes of septic arthritis caused by Pseudomonas aeruginosa occurred in a patient with an infected vascular graft."	1.29	Recurrent pseudomonas septic arthritis. ( Price, T; Vickers, MH, 1993)
"Relapse is common even after apparently adequate therapy and may be seen in up to 25% of cases that involve streptomycin-resistant strains."	1.28	Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy. ( Dietrich, KA; Dixon, WA; Landau, SW; Miller, WC; Sacher, HL; Sacher, ML, 1991)
"A case of typhoid fever caused by a multiply antibiotic resistant strain of Salmonella typhi is reported."	1.28	Septicaemia caused by an imported strain of multiply antibiotic resistant Salmonella typhi successfully treated with ciprofloxacin. ( Bhana, R; Coovadia, Y; Seebaran, A, 1990)
" Therapy has traditionally consisted of the long-term administration of combination parenteral antibiotics, but morbidity and mortality remain substantial despite this therapy."	1.28	Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. ( Kamerer, DB; Matador, A; Muder, RR; Rubin, J; Stoehr, G; Yu, VL, 1989)
" The higher dosage showed a reduced amount of reinfections and relapses (19% and 16% versus 5% and 0%)."	1.28	Two different dosages of ciprofloxacin in patients with respiratory tract infections. ( Brutel de la Rivière, T; Daniëls-Bosman, MS; ten Velde, GP, 1989)
"Ciprofloxacin was well tolerated and effective in most of the ambulatory patients with refractory Gram-negative bacillary infection."	1.27	Oral ciprofloxacin in refractory gram-negative bacillary infections. ( Bryant, RE; Hartstein, AI, 1987)
" Depending on renal function the dosage varied from 100 mg once daily to 250 mg twice daily."	1.27	The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection. ( Brown, EM; Morris, R; Stephenson, TP, 1986)

Timeframe	Studies, this research(%)	All Research%
pre-1990	20 (12.66)	18.7374
1990's	49 (31.01)	18.2507
2000's	50 (31.65)	29.6817
2010's	34 (21.52)	24.3611
2020's	5 (3.16)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
Conservative Treatment of Acute Appendicitis in Children Pilot Trial[NCT01572558]		51 participants (Actual)	Interventional	2012-02-29	Completed
The Efficacy and Safety of 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-Induced Liver Injury[NCT03266146]	Phase 1/Phase 2	90 participants (Actual)	Interventional	2017-09-02	Completed
A Randomized Controlled Clinical Trial on the Efficacy and Safety of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-induced Liver Injury[NCT02651350]	Phase 1/Phase 2	80 participants (Actual)	Interventional	2015-12-31	Completed
A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis[NCT00583531]	Phase 2	2 participants (Actual)	Interventional	2007-03-31	Terminated (stopped due to Lack of enrollment)
"A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis (PROF). The PROF Study."[NCT05938465]	Phase 1/Phase 2	50 participants (Anticipated)	Interventional	2023-10-11	Recruiting
Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome: a Randomized Double Blind Placebo Controlled Study[NCT00786123]		40 participants (Anticipated)	Interventional	2006-05-31	Completed
Does the Use of Topical Otic Drops at the Time of Tympanostomy Tube Placement Improve Outcomes When no Middle Ear Effusion is Present at the Time of Surgery[NCT03655665]	Phase 4	125 participants (Anticipated)	Interventional	2019-05-16	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. The Cochrane database of systematic reviews, 2022, 11-24, Volume: 11 Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone	2022
A 34-year-old man with urethral discharge. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Mar-19, Volume: 185, Issue:5 Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Gonorrhea; Homosexuality, Male;	2013
Perianal cutaneous malakoplakia in an immunocompetent patient. Dermatology online journal, 2010, Jan-15, Volume: 16, Issue:1 Topics: Anti-Bacterial Agents; Anus Diseases; Anus Neoplasms; Ascorbic Acid; Ciprofloxacin; Combined Modalit	2010
[Skin infection due to Serratia marcescens in an immunocompetent patient]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:3 Topics: Abscess; Adult; Anti-Bacterial Agents; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Exudate	2011
[Actinomycosis]. Praxis, 2004, Feb-04, Volume: 93, Issue:6 Topics: Actinomycosis, Cervicofacial; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Ciprofloxa	2004
[Probiotics--should we change the treatment strategy for pouchitis?]. Ugeskrift for laeger, 2006, Oct-09, Volume: 168, Issue:41 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Evidence-Based Medicine; Humans; Metron	2006
[New prospects in the treatment of urinary tract infections with modified-release ciprofloxacin]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2006, Volume: 78, Issue:3 Suppl 1 Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Clinical Trials, Phase III as Topic; D	2006
[Early and timely therapy: when to interrupt antibiotic therapy in nosocomial acquired pneumonia?]. Le infezioni in medicina, 2007, Volume: 15, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Cross Infection; Drug Administration Schedule;	2007
Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:1 Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Gentamicins; Humans; Recurrence; Tularemia	1995
[Current role of aminoglycosides in the treatment of acute pyelonephritis]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 1998, Volume: 8, Issue:6 Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil	1998
[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis]. Presse medicale (Paris, France : 1983), 2001, Oct-27, Volume: 30, Issue:31 Pt 2 Topics: Acute Disease; Adrenal Cortex Hormones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; A	2001
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review. The Journal of infection, 2002, Volume: 44, Issue:1 Topics: Adult; Anti-Infective Agents; Cefazolin; Ceftriaxone; Cephalosporins; Chronic Disease; Ciprofloxacin	2002
Clinical impact of newer quinolones: influence on normal microflora. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:1 Topics: Bacterial Infections; Ciprofloxacin; Humans; Immune Tolerance; Intestinal Mucosa; Norfloxacin; Oroph	1989

Article	Year
Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults. Urologia internationalis, 2019, Volume: 102, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chemotherapy, Adjuvant; Ciprofloxacin; Double-Blind	2019
Nonoperative treatment with antibiotics versus surgery for acute nonperforated appendicitis in children: a pilot randomized controlled trial. Annals of surgery, 2015, Volume: 261, Issue:1 Topics: Abdominal Pain; Acute Disease; Adolescent; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child;	2015
The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006. Annals of tropical paediatrics, 2009, Volume: 29, Issue:1 Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Double-	2009
A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis. Tropical doctor, 2009, Volume: 39, Issue:4 Topics: Adult; Anti-Infective Agents; Brucellosis; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Fe	2009
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatric pulmonology, 2012, Volume: 47, Issue:2 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Male	2012
Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Alimentary pharmacology & therapeutics, 2003, Volume: 18, Issue:11-12 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anus Diseases; Azathioprine;	2003
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut, 2004, Volume: 53, Issue:1 Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Feces; Female; Humans; Male; Metronidazole; Middle	2004
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut, 2004, Volume: 53, Issue:1 Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Feces; Female; Humans; Male; Metronidazole; Middle	2004
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut, 2004, Volume: 53, Issue:1 Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Feces; Female; Humans; Male; Metronidazole; Middle	2004
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut, 2004, Volume: 53, Issue:1 Topics: Adult; Ciprofloxacin; Drug Therapy, Combination; Feces; Female; Humans; Male; Metronidazole; Middle	2004
Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC gastroenterology, 2004, Mar-15, Volume: 4 Topics: Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Double-Blind Method; Drug Therapy, Combination;	2004
Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva gastroenterologica e dietologica, 2004, Volume: 50, Issue:2 Topics: Acute Disease; Adjuvants, Immunologic; Administration, Oral; Aged; Analysis of Variance; Anti-Infect	2004
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Alimentary pharmacology & therapeutics, 2005, Oct-15, Volume: 22, Issue:8 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Female; Follow-Up Studies; H	2005
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Alimentary pharmacology & therapeutics, 2005, Oct-15, Volume: 22, Issue:8 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Female; Follow-Up Studies; H	2005
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Alimentary pharmacology & therapeutics, 2005, Oct-15, Volume: 22, Issue:8 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Female; Follow-Up Studies; H	2005
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Alimentary pharmacology & therapeutics, 2005, Oct-15, Volume: 22, Issue:8 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Female; Follow-Up Studies; H	2005
Ciprofloxacin/dexamethasone drops decrease the incidence of physician and patient outcomes of otorrhea after tube placement. International journal of pediatric otorhinolaryngology, 2007, Volume: 71, Issue:5 Topics: Administration, Topical; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Cerebrospinal Fluid	2007
Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Archives of internal medicine, 1995, Mar-13, Volume: 155, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Colony Count, Microbial; D	1995
[Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults]. Klinicheskaia meditsina, 1994, Volume: 72, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Mal	1994
Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women. The Journal of urology, 1994, Volume: 152, Issue:1 Topics: Adult; Ciprofloxacin; Coitus; Female; Humans; Norfloxacin; Ofloxacin; Prospective Studies; Recurrenc	1994
Short course ciprofloxacin therapy for enteric fever. The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:7 Topics: Adult; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Paratyphoid Fever; Recurre	1993
A comparative study of short course ciprofloxacin treatment in typhoid and paratyphoid fever. Drugs, 1995, Volume: 49 Suppl 2 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Paratyphoid	1995
Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:5 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fever of Unknown	1995
Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. The Journal of urology, 1997, Volume: 157, Issue:3 Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Coitus; Female; Follow-Up Studies; Humans;	1997
Multicenter study of the efficacy and safety of oral ciprofloxacin in the treatment of chronic suppurative otitis media in adults. The French Study Group. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1997, Volume: 117, Issue:1 Topics: Administration, Oral; Age Factors; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Family Pra	1997
A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. Chest, 1998, Volume: 113, Issue:1 Topics: Adolescent; Adult; Anti-Infective Agents; Bronchitis; Canada; Chronic Disease; Ciprofloxacin; Cost-B	1998
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. The Annals of otology, rhinology, and laryngology, 1999, Volume: 108, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infe	1999
Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis and rheumatism, 1999, Volume: 42, Issue:9 Topics: Anti-Infective Agents; Arthritis, Reactive; Ciprofloxacin; Double-Blind Method; Female; HLA-B27 Anti	1999
[Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years]. Ugeskrift for laeger, 2000, Feb-14, Volume: 162, Issue:7 Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Double-Blind	2000
Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Annals of internal medicine, 2000, Jun-06, Volume: 132, Issue:11 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Chronic Di	2000
Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology, 2002, Volume: 59, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Admi	2002
A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. The American journal of medicine, 1992, Apr-06, Volume: 92, Issue:4A Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; F	1992
Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. The New Zealand medical journal, 1992, Mar-25, Volume: 105, Issue:930 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Escherichia coli Infect	1992
Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:9 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Gentamicins; Humans; Metabolic	1991
Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis. The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:6 Topics: Acute Disease; Adolescent; Adult; Brucellosis; Ciprofloxacin; Doxycycline; Female; Humans; Male; Mid	1990
Comparative efficacy of ciprofloxacin versus josamycin in the treatment of acute, recurrent, or exacerbated bronchitis. The American journal of medicine, 1989, Nov-30, Volume: 87, Issue:5A Topics: Acute Disease; Bacteria; Bacterial Infections; Bronchitis; Ciprofloxacin; Humans; Josamycin; Microbi	1989
Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:12 Topics: Adolescent; Adult; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Administration Sch	1989
Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2 Topics: Adolescent; Adult; Ciprofloxacin; Drug Administration Schedule; Escherichia coli; Escherichia coli I	1987

Article	Year
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistan	2010
Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study. PloS one, 2021, Volume: 16, Issue:9 Topics: Administration, Oral; Adolescent; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Ce	2021
Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy. Gastroenterology, 2020, Volume: 158, Issue:3 Topics: Adult; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Cytokines; Drug Resistance, Bacterial; Feces;	2020
Chronic Suppurative Otitis Media: A Case Report. Infectious disorders drug targets, 2020, Volume: 20, Issue:2 Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Drug Resistance, Multiple, Bacterial;	2020
A data-based mathematical modelling study to quantify the effects of ciprofloxacin and ampicillin on the within-host dynamics of Journal of the Royal Society, Interface, 2020, Volume: 17, Issue:168 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Humans; Mice; Microbial Sensitivity Tests	2020
Rhinoscleroma: a chronic infectious disease of poor areas with characteristic histological features - report of a series of six cases. Tropical doctor, 2018, Volume: 48, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Chronic Disease; Ciprofloxacin; Female; Humans; Mal	2018
Recurrent otorrhea in chronic suppurative otitis media: is biofilm the missing link? European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2017, Volume: 274, Issue:7 Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Biofilms; Child; Child, Preschool	2017
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation. BMJ case reports, 2017, Sep-25, Volume: 2017 Topics: Adult; Anti-Bacterial Agents; Azathioprine; Cholangitis, Sclerosing; Ciprofloxacin; Drug Therapy, Co	2017
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. Tropical doctor, 2018, Volume: 48, Issue:3 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Dr	2018
Stump Appendicitis Management. The American surgeon, 2018, Dec-01, Volume: 84, Issue:12 Topics: Administration, Oral; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ciprofloxacin; Female; Huma	2018
Thorax, 2019, Volume: 74, Issue:8 Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage; Ceftazidime; Child, Preschool; Ciprofloxacin; Clavula	2019
Cases of typhoid fever in Copenhagen region: a retrospective study of presentation and relapse. BMC research notes, 2013, Aug-11, Volume: 6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Denmark; Drug Resistance, Bacterial; Female	2013
Squamous cell carcinoma of the penis and topical combination corticosteroid products: a cautionary case. Dermatology online journal, 2013, Jul-14, Volume: 19, Issue:7 Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Balanitis; Betamethasone; Carcinoma, Squamous Cell;	2013
Role of probiotics in the management of pouchitis. Current pharmaceutical design, 2014, Volume: 20, Issue:28 Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Intestines; Metronidazol	2014
Is vesicolithotomy with bladder wash the answer for rectovesical fistula secondary to neglected vesical stone? Complicated presentation but simple management. Saudi medical journal, 2014, Volume: 35, Issue:4 Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Humans; Male; Rectal Fistula; Recurrence; Urinary Bladd	2014
Factors associated with ciprofloxacin-resistant Escherichia coli urinary tract infections in discharged ED patients. The American journal of emergency medicine, 2015, Volume: 33, Issue:10 Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Emergenc	2015
Clostridium difficile infection in rural Ontario: a retrospective multisite population-based study. Canadian journal of rural medicine : the official journal of the Society of Rural Physicians of Canada = Journal canadien de la medecine rurale : le journal officiel de la Societe de medecine rurale du Canada, 2015,Fall, Volume: 20, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Catchment Area, Health; Child; Ch	2015
Gardnerella vaginalis: An overlooked pathogen in male patients? Medecine et maladies infectieuses, 2015, Volume: 45, Issue:10 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance,	2015
Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic. Revista espanola de enfermedades digestivas, 2015, Volume: 107, Issue:12 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chemical and Drug Induced Live	2015
Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic. Revista espanola de enfermedades digestivas, 2015, Volume: 107, Issue:12 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chemical and Drug Induced Live	2015
Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic. Revista espanola de enfermedades digestivas, 2015, Volume: 107, Issue:12 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chemical and Drug Induced Live	2015
Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic. Revista espanola de enfermedades digestivas, 2015, Volume: 107, Issue:12 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chemical and Drug Induced Live	2015
Microbiological Characteristics of Unresolved Acute Uncomplicated Cystitis. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:5 Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce	2016
Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders. The Journal of infectious diseases, 2017, 08-01, Volume: 216, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacteriuria; Chitosan; Ciprofloxacin; Escherichia coli Infections; F	2017
A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis. The American journal of medicine, 2017, Volume: 130, Issue:7 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Administration Sch	2017
[Acute myocarditis after visiting Pakistan]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:28-29 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; C-Reactive Protein; Ceftriaxone;	2008
Recurrence of peripheral ulcerative keratitis on the corneoscleral button in a young man treated successfully with oral corticosteroids. Cornea, 2008, Volume: 27, Issue:7 Topics: Administration, Oral; Adult; Amnion; Anti-Infective Agents; Ciprofloxacin; Corneal Transplantation;	2008
Ciprofloxacin-induced seizures in a healthy patient. The New Zealand medical journal, 2008, Jul-04, Volume: 121, Issue:1277 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Recurrence; Seizures; Urinary Tract Inf	2008
Postoperative Mycobacterium abscessus nodular conjunctivitis. Clinical & experimental ophthalmology, 2008, Volume: 36, Issue:4 Topics: Aged; Anti-Bacterial Agents; Cataract Extraction; Ciprofloxacin; Clarithromycin; Conjunctivitis; Dru	2008
The trials of the returning traveler: ciprofloxacin failure in enteric fever. Minnesota medicine, 2008, Volume: 91, Issue:11 Topics: Adult; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; India	2008
Successful treatment of dissecting cellulitis with ciprofloxacin. Clinical and experimental dermatology, 2010, Volume: 35, Issue:4 Topics: Adult; Anti-Infective Agents; Cellulitis; Ciprofloxacin; Humans; Male; Recurrence; Scalp Dermatoses	2010
Recurrent cytomegalovirus infection in ileal pouch-anal anastomosis for ulcerative colitis. Inflammatory bowel diseases, 2010, Volume: 16, Issue:6 Topics: Ciprofloxacin; Colitis, Ulcerative; Colonic Pouches; Cytomegalovirus Infections; Dietary Supplements	2010
Malignant otitis externa: case series. The Journal of laryngology and otology, 2010, Volume: 124, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Cranial Nerve Diseases; Diabetes Mell	2010
Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. Swiss medical weekly, 2010, Volume: 140 Topics: Acute Disease; Aged; Anti-Infective Agents, Urinary; Bacteremia; Bacteriuria; Ciprofloxacin; Cross-S	2010
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin]. Medecine et maladies infectieuses, 2010, Volume: 40, Issue:12 Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial;	2010
[Unexpected complication following esophageal variceal hemorrhage - Case 2/2011]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:5 Topics: Amiodarone; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inh	2011
The value of successive Infecton scans in assessing the presence of chronic bone and joint infection and in predicting its evolution after treatment and after a prolonged follow-up. Nuclear medicine communications, 2011, Volume: 32, Issue:11 Topics: Adult; Aged; Arthrography; Blood Sedimentation; Bone and Bones; Bone Diseases, Infectious; C-Reactiv	2011
Photo quiz: A 36-year-old with recurrent conjunctivitis. Journal of clinical microbiology, 2012, Volume: 50, Issue:2 Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacterial Typing Techniques; B	2012
The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Diseases of the colon and rectum, 2012, Volume: 55, Issue:3 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Colonic Pou	2012
Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A. Pathogens and global health, 2012, Volume: 106, Issue:6 Topics: Abscess; Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Breast Diseases; Ceftriax	2012
Gonococcal perianal abscess: re-emergence after cessation of co-trimoxazole. Sexually transmitted infections, 2002, Volume: 78, Issue:5 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Gonorrhea; HIV Infections; Homosexuality, Male; Humans;	2002
Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa. Journal of clinical microbiology, 2002, Volume: 40, Issue:12 Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Typing Techni	2002
[Pneumococcus and quinolone resistance]. Archivos de bronconeumologia, 2003, Volume: 39, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Child, Preschool; Ciproflo	2003
Septic arthritis caused by Erysipelothrix rhusiopathiae infection after arthroscopically assisted anterior cruciate ligament reconstruction. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2003, Volume: 19, Issue:3 Topics: Adolescent; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Arthritis, Infectious;	2003
[Relapsing Staphylococcus lugdunensis septic arthritis associated with a knee prosthesis]. Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:4 Topics: Aged; Arthritis, Infectious; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Autoimmune Dise	2003
[Pilot study of coadjuvant treatment of recurrent cystitis in women by means of AM3 (Immnoferon)]. Actas urologicas espanolas, 2003, Volume: 27, Issue:3 Topics: Adjuvants, Immunologic; Amoxicillin; Calcium Phosphates; Ciprofloxacin; Clavulanic Acid; Cystitis; D	2003
Gonorrhoea, test of cure, evidence-based medicine and the Emperor's new clothes! International journal of STD & AIDS, 2004, Volume: 15, Issue:1 Topics: Anti-Infective Agents; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Evidenc	2004
[Recurrence of bacterial endophthalmitis after penetrating keratoplasty]. Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:2 Topics: Abscess; Adult; Amphotericin B; Aqueous Humor; Candida albicans; Candidiasis; Ciprofloxacin; Drug Th	2004
Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients. Digestive surgery, 2004, Volume: 21, Issue:3 Topics: Adenomatous Polyposis Coli; Adult; Anti-Infective Agents; Ciprofloxacin; Colitis, Ulcerative; Female	2004
[Ulcerative colitis. Chronic active course]. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9 Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Diseas	2004
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess. Urology, 2004, Volume: 64, Issue:4 Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections;	2004
Case report: greater meningeal inflammation in lumbar than in ventricular region in human bacterial meningitis. Critical care (London, England), 2004, Volume: 8, Issue:6 Topics: Adult; Anti-Infective Agents; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Chordoma; Ciprofloxac	2004
Oxymetazoline is equivalent to ciprofloxacin in preventing postoperative otorrhea or tympanostomy tube obstruction. The Laryngoscope, 2005, Volume: 115, Issue:2 Topics: Administration, Topical; Adolescent; Adrenergic alpha-Agonists; Anti-Infective Agents; Antibiotic Pr	2005
Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. Chemotherapy, 2005, Volume: 51, Issue:6 Topics: Anti-Infective Agents; Brucellosis; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Male; Microbi	2005
Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem. The Journal of infection, 2005, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial;	2005
Severe recurrent Crohn's disease of the ileocolonic anastomosis disappearing completely with antibacterial therapy. Gut, 2005, Volume: 54, Issue:12 Topics: Adult; Anastomosis, Surgical; Anti-Bacterial Agents; Ciprofloxacin; Colon; Crohn Disease; Humans; Il	2005
Pasteurella multocida infection of a total knee arthroplasty after a "dog lick". Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2006, Volume: 14, Issue:10 Topics: Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Ciprofloxacin; D	2006
A case of bilateral psoas abscesses and lumbar osteomyelitis due to recurrent salmonella infection. Journal of the National Medical Association, 2006, Volume: 98, Issue:11 Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Mi	2006
A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis. The Pediatric infectious disease journal, 2007, Volume: 26, Issue:4 Topics: Amphotericin B; Anti-Infective Agents; Antiprotozoal Agents; Child, Preschool; Ciprofloxacin; Geneti	2007
[Cholangitis with hepatic microabscesses caused by Salmonella enterica serovar choleraesuis]. Deutsche medizinische Wochenschrift (1946), 2007, Jun-01, Volume: 132, Issue:22 Topics: Aged; Anti-Bacterial Agents; C-Reactive Protein; Cholangitis; Ciprofloxacin; Diagnosis, Differential	2007
Electronic clinical challenges and images in GI. Ileal diverticulitis. Gastroenterology, 2008, Volume: 134, Issue:7 Topics: Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Digestive System Surgical Procedures; Diver	2008
An unusual presentation of recurrent corneal abrasion in a lepromatous patient with impaired corneal sensation. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1995, Volume: 63, Issue:3 Topics: Anti-Infective Agents; Atropine; Ciprofloxacin; Cornea; Corneal Diseases; Corneal Injuries; Humans;	1995
Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis. Gut, 1995, Volume: 37, Issue:1 Topics: Adult; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistanc	1995
Recrudescence and relapse of meningococcal meningitis and septicaemia. Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:3 Topics: Administration, Oral; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Chloramphenicol; Ciproflo	1995
A case of recurrent typhoid fever in the United States: importance of the grandmother connection and the use of large restriction fragment pattern analysis of genomic DNA for strain comparison. The Pediatric infectious disease journal, 1994, Volume: 13, Issue:12 Topics: Aged; Carrier State; Child; Ciprofloxacin; Disease Transmission, Infectious; DNA, Bacterial; Electro	1994
Treatment and prevention of relapses of CAPD Pseudomonas peritonitis. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1993, Volume: 9 Topics: Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Peritoneal Dialysis, Co	1993
Recurrent pseudomonas septic arthritis. Postgraduate medical journal, 1993, Volume: 69, Issue:818 Topics: Aged; Arthritis, Infectious; Blood Vessel Prosthesis; Cefsulodin; Ciprofloxacin; Drug Therapy, Combi	1993
[Effect of ciprofloxacin therapy in duration of bacterial excretion in acute salmonella gastroenteritis]. Schweizerische medizinische Wochenschrift, 1993, Oct-16, Volume: 123, Issue:41 Topics: Adult; Ciprofloxacin; Colony Count, Microbial; Feces; Female; Gastroenteritis; Humans; Male; Middle	1993
Prevention of recurrent central venous catheter infections with a novel flush solution in a patient on long-term hemodialysis. Pediatric nephrology (Berlin, Germany), 1993, Volume: 7, Issue:4 Topics: Bacteremia; Catheterization, Central Venous; Child, Preschool; Ciprofloxacin; Drug Therapy, Combinat	1993
Ciprofloxacin for treatment of severe typhoid fever in children. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:5 Topics: Body Temperature; Carrier State; Child; Child, Preschool; Ciprofloxacin; Critical Illness; Humans; I	1993
Recurrent infection of continuous subcutaneous insulin infusion sites with Mycobacterium fortuitum. Diabetes care, 1995, Volume: 18, Issue:9 Topics: Anti-Bacterial Agents; Blood Glucose; Cefoxitin; Ciprofloxacin; Diabetes Mellitus, Type 1; Drug Ther	1995
[Pure angiocholitic form of congenital hepatic fibrosis]. Gastroenterologie clinique et biologique, 1996, Volume: 20, Issue:2 Topics: Anti-Infective Agents; Cholangitis; Ciprofloxacin; Combined Modality Therapy; Female; Humans; Liver	1996
Myasthenia gravis and ciprofloxacin. Acta neurologica Scandinavica, 1996, Volume: 94, Issue:6 Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Electromyography; Female; Humans; Male; Myasthenia Gravi	1996
Efficacy of ototopical ciprofloxacin in pediatric patients with otorrhea. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1997, Volume: 116, Issue:4 Topics: Administration, Topical; Adolescent; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin;	1997
A relapse of paratyphoid fever after treatment with ciprofloxacin in a child with congenital biliary atresia. Acta paediatrica (Oslo, Norway : 1992), 1997, Volume: 86, Issue:5 Topics: Anti-Infective Agents; Biliary Atresia; Ciprofloxacin; Humans; Infant; Male; Osteomyelitis; Paratyph	1997
Bilateral anterior uveitis and retinal haemorrhages after administration of trimethoprim. Acta ophthalmologica Scandinavica, 1997, Volume: 75, Issue:3 Topics: Administration, Topical; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Therapy, Combina	1997
Recurrent Clostridium difficile disease following ciprofloxacin use. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:9 Topics: Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis	1997
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination. Clinical transplantation, 1998, Volume: 12, Issue:2 Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Cyclophosphamide; Disease-	1998
[Observation of 212 cases of typhoid fever treated with FQNS]. Zhonghua yi xue za zhi, 1997, Volume: 77, Issue:5 Topics: Adult; Anti-Infective Agents; Child; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Recurrence; Typho	1997
Prolonged ciprofloxacin therapy fails to prevent reactivation tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:4 Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Humans; Male; Mycobacterium tuber	1998
[Late recurrence of endocarditis caused by Coxiella burnetii following prosthetic valve substitution and prolonged antibiotic treatment]. Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Coxiella burnetii; Doxycycline; Endocar	1999
Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. The Journal of infectious diseases, 1999, Volume: 179, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Amoxicillin; Anti-HIV Agents; Anti-Infective Agents; Bact	1999
Reactivation of osteomyelitis caused by Staphylococcus aureus after 50 years. Journal of the American Geriatrics Society, 1999, Volume: 47, Issue:8 Topics: Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Femur; Humans; Male; Muscle	1999
Neutrophilic eccrine hidradenitis secondary to infection with Serratia marcescens. The British journal of dermatology, 2000, Volume: 142, Issue:4 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Ependymoma; Hidradenitis; Humans; Male; Postoperative C	2000
Glyburide-ciprofloxacin interaction with resistant hypoglycemia. Annals of emergency medicine, 2000, Volume: 36, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic N	2000
Recurrent granulomatous acute interstitial nephritis induced by commonly used antibiotics. The Journal of the Association of Physicians of India, 1999, Volume: 47, Issue:6 Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Dexamethaso	1999
[Some problems of the current therapy of infective endocarditis]. Terapevticheskii arkhiv, 2000, Volume: 72, Issue:9 Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infect	2000
Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 37, Issue:1 Topics: Adult; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Inje	2001
Relapse of multiresistant Salmonella typhi after combined therapy with ciprofloxacin and ceftriaxone. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:3 Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial	2000
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy. AIDS (London, England), 2001, Mar-30, Volume: 15, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infecti	2001
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]. Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:2 Pt 2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin	2001
Relapse of Salmonella infection after ciprofloxacin. The Journal of hospital infection, 1992, Volume: 20, Issue:1 Topics: Aged; Carrier State; Ciprofloxacin; Diarrhea; Female; Humans; Recurrence; Salmonella Infections; Sal	1992
Relationship between peritonitis and exit site infections in CAPD. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1992, Volume: 8 Topics: Ciprofloxacin; Humans; Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurren	1992
Ciprofloxacin and Salmonella carriage. The Journal of hospital infection, 1992, Volume: 22, Issue:3 Topics: Carrier State; Ciprofloxacin; Diarrhea; Feces; Humans; Recurrence; Salmonella; Salmonella Infections	1992
Salmonella, Campylobacter and Shigella in HIV-seropositive patients. AIDS (London, England), 1992, Volume: 6, Issue:12 Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Campylobacter Infections; CD4-Positive T-Lymphoc	1992
Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:1 Topics: Administration, Oral; Adult; Aged; Brucellosis; Ciprofloxacin; Drug Evaluation; Female; Follow-Up St	1992
[Ciprofloxacin-omeprazole combination therapy for eradication of Helicobacter pylori]. Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Campylobacter Infections; Ciprofloxacin; Drug	1991
Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy. Journal of clinical pharmacology, 1991, Volume: 31, Issue:8 Topics: Adult; Ampicillin; beta-Lactamases; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Endoca	1991
Septicaemia caused by an imported strain of multiply antibiotic resistant Salmonella typhi successfully treated with ciprofloxacin. Tropical and geographical medicine, 1990, Volume: 42, Issue:4 Topics: Ciprofloxacin; Drug Resistance, Microbial; Feces; Humans; India; Male; Middle Aged; Recurrence; Salm	1990
Relapsing yersinia infection. BMJ (Clinical research ed.), 1990, Jun-30, Volume: 300, Issue:6741 Topics: Adult; Chronic Disease; Ciprofloxacin; Female; Humans; Recurrence; Yersinia enterocolitica; Yersinia	1990
[Ciprofloxacin: a solution for recurrent bacteremia caused by Salmonella non typhi in acquired immunodeficiency syndrome?]. Enfermedades infecciosas y microbiologia clinica, 1989, Volume: 7, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Ciprofloxacin; Humans; Male; Middle Aged; Recurrence; Salmonella	1989
Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex. BMJ (Clinical research ed.), 1989, Mar-04, Volume: 298, Issue:6673 Topics: Administration, Oral; Adult; AIDS-Related Complex; Anaphylaxis; Ciprofloxacin; Humans; Male; Otitis	1989
Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Archives of otolaryngology--head & neck surgery, 1989, Volume: 115, Issue:9 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Diabetes Complic	1989
Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication. Archives of internal medicine, 1989, Volume: 149, Issue:10 Topics: Aged; Chromatography, High Pressure Liquid; Ciprofloxacin; Cross Infection; Drug Resistance, Microbi	1989
Ciprofloxacin for Salmonella bacteremia in the acquired immunodeficiency syndrome (AIDS). Annals of internal medicine, 1989, Jun-15, Volume: 110, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Adult; Ciprofloxacin; Humans; Male; Middle Aged; Recurrence; Sal	1989
Two different dosages of ciprofloxacin in patients with respiratory tract infections. Pharmaceutisch weekblad. Scientific edition, 1989, Aug-25, Volume: 11, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Lung Diseases, Obstructive; Male; Mid	1989
Ciprofloxacin for cholangitis. Lancet (London, England), 1987, Jul-25, Volume: 2, Issue:8552 Topics: Aged; Cholangitis; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Recurrence	1987
Relapsing malignant otitis externa successfully treated with ciprofloxacin. The Journal of laryngology and otology, 1988, Volume: 102, Issue:10 Topics: Aged; Ciprofloxacin; Humans; Male; Otitis Externa; Pseudomonas Infections; Radionuclide Imaging; Rec	1988
[The effectiveness of ciprofloxacin in bacterial skin infections]. Zeitschrift fur Hautkrankheiten, 1988, Dec-15, Volume: 63, Issue:12 Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Drug Administration Schedule; Erysipelas;	1988
The influence of ciprofloxacin treatment in vivo on cell-mediated immunity to Listeria monocytogenes. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology, 1988, Volume: 268, Issue:2 Topics: Ampicillin; Animals; Ciprofloxacin; Female; Hypersensitivity, Delayed; Immunity, Cellular; Immunizat	1988
Bay o 9867 (ciprofloxacin) in the treatment of urinary tract infections in elderly patients. Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques, 1988, Volume: 10, Issue:4 Topics: Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Male; Middle Aged; Recurrence; Urinary Tract	1988
Ciprofloxacin treatment of recurrent Salmonella typhimurium septicaemia in a patient with acquired immune deficiency syndrome. The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adult; Ciprofloxacin; Humans; Male; Recurrence; Salmonella Infec	1986
Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Male; Middle Ag	1987
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cellulitis; Ciprofloxacin; Enterob	1987
Oral ciprofloxacin in refractory gram-negative bacillary infections. International journal of clinical pharmacology research, 1987, Volume: 7, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Chronic Disease; Ciprofloxacin; Female; Gram-N	1987
The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection. The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D Topics: Adult; Aged; Chronic Disease; Ciprofloxacin; Female; Humans; Male; Middle Aged; Pseudomonas Infectio	1986

ciprofloxacin and Recrudescence

Research Excerpts

Research

Studies (158)

Authors

Clinical Trials (7)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Blango, MG	2
Mulvey, MA	2
Lignieres, G	1
Birgy, A	1
Jung, C	1
Bonacorsi, S	1
Levy, C	1
Angoulvant, F	1
Grimprel, E	1
Dommergues, MA	1
Gillet, Y	1
Craiu, I	1
Rybak, A	1
De Pontual, L	1
Dubos, F	1
Cixous, E	1
Gajdos, V	1
Pinquier, D	1
Andriantahina, I	1
Soussan-Banini, V	1
Georget, E	1
Launay, E	1
Vignaud, O	1
Cohen, R	1
Madhi, F	1
Kuehn, R	3
Stoesser, N	3
Eyre, D	3
Darton, TC	3
Basnyat, B	3
Parry, CM	3
Dubinsky, V	1
Reshef, L	1
Bar, N	1
Keizer, D	1
Golan, N	1
Rabinowitz, K	1
Godny, L	1
Yadgar, K	1
Zonensain, K	1
Tulchinsky, H	1
Gophna, U	1
Dotan, I	1
Yazdi, MMK	1
Ghalavand, Z	1
Yazdi, AK	1
Kodori, M	1
Taheri, M	1
Tabriz, MS	1
Eslami, G	1
Vlazaki, M	1
Rossi, O	1
Price, DJ	1
McLean, C	1
Grant, AJ	1
Mastroeni, P	1
Restif, O	1
Efared, B	1
Hammas, N	1
Gabrielle, AE	1
Ben Mansour, N	1
El Fatemi, H	1
Chbani, L	1
Jensen, RG	1
Johansen, HK	1
Bjarnsholt, T	1
Eickhardt-Sørensen, SR	1
Homøe, P	1
Hey, P	1
Lokan, J	1
Johnson, P	1
Gow, P	1
Bandyopadhyay, R	1
Balaji, V	1
Yadav, B	1
Jasmine, S	1
Sathyendra, S	1
Rupali, P	1
Rhyne, RR	1
Hale, AL	1
Watson, DS	1
Smith, DE	1
Costache, RC	1
Novac, B	1
Bardan, TR	1
Agapie, DN	1
Edu, A	1
Harun, SN	1
Holford, NHG	1
Grimwood, K	1
Wainwright, CE	1
Hennig, S	1
Rebick, GW	1
Allen, VG	1
Gold, WL	1
Barrett, FC	1
Knudsen, JD	1
Johansen, IS	1
Laarman, R	1
Blackmon, J	1
Rajpara, A	1
Aires, D	1
Guslandi, M	1
Elnaim, AK	1
Mohamed, MM	1
Svensson, JF	1
Patkova, B	1
Almström, M	1
Naji, H	1
Hall, NJ	1
Eaton, S	1
Pierro, A	1
Wester, T	1
Kratochwill, L	1
Powers, M	1
McGraw, MA	1
King, L	1
O'Neill, JM	1
Venkat, A	1
Babey, K	1
Kelton, S	1
Milne, WK	1
Muileboom, J	1
Voth, B	1
Kelly, L	1
Brintnell, WC	1
Dickins, T	1
Armitage, C	1
Babics, A	1
Roussellier, P	1
Moreno, L	1
Sánchez-Delgado, J	1
Vergara, M	1
Casas, M	1
Miquel, M	1
Dalmau, B	1
Kim, HY	1
Lee, SJ	1
Lee, DS	1
Yoo, JM	1
Choe, HS	1
Erman, A	1
Hergouth, VK	1
Kos, MK	1
Veranic, P	1
Fox, MT	1
Melia, MT	1
Same, RG	1
Conley, AT	1
Tamma, PD	1
Türoff, A	1
Vollnberg, H	1
Kohler, BM	1
Wahid, WA	1
Selvaraja, V	1
Bakiah, S	1
Ibrahim, M	1
Darwish, T	1
Merani, R	1
Orekondy, S	1
Gottlieb, T	2
Janarthanan, P	1
McCarthy, S	1
Karim, R	1
Booth, F	1
Bormann, AM	1
Boulware, DR	1
Molyneux, EM	1
Mankhambo, LA	1
Phiri, A	2
Graham, SM	1
Forsyth, H	1
Walsh, AL	1
Wilson, LK	1
Molyneux, ME	1
Onderdijk, AJ	1
Boer, J	1
Keramat, F	1
Ranjbar, M	1
Mamani, M	1
Hashemi, SH	1
Zeraati, F	1
He, X	1
Bennett, AE	2
Lian, L	1
Shen, B	2
Shawaf, AZ	1
Boushi, LA	1
Douri, TH	1
Ali, T	1
Meade, K	1
Anari, S	1
ElBadawey, MR	1
Zammit-Maempel, I	1
Nicoletti, J	1
Kuster, SP	1
Sulser, T	1
Zbinden, R	1
Ruef, C	1
Ledergerber, B	1
Weber, R	1
Gaborieau, V	1
Weill, FX	1
Marchou, B	1
Werner, CR	1
Riessen, R	1
Gregor, M	1
Bitzer, M	1
Giráldez, P	1
Mayo, E	1
Pavón, P	1
Losada, A	1
Mayer-Hamblett, N	1
Kronmal, RA	1
Gibson, RL	1
Rosenfeld, M	1
Retsch-Bogart, G	1
Treggiari, MM	1
Burns, JL	1
Khan, U	1
Ramsey, BW	1
Malamitsi, J	1
Papadopoulos, A	1
Vezyrgianni, A	1
Dalianis, K	1
Boutsikou, M	1
Giamarellou, H	1
Burd, EM	1
Sharp, SE	1
Suzuki, H	1
Ogawa, H	1
Shibata, C	1
Haneda, S	1
Watanabe, K	1
Takahashi, K	1
Funayama, Y	1
Sasaki, I	1
Fernando, S	1
Molland, JG	1
Read, T	1
Mijch, A	1
Ostergaard, L	2
Moodley, P	1
Martin, IM	1
Ison, CA	1
Sturm, AW	1
Bello, S	1
Torres, A	1
Allianatos, PG	1
Tilentzoglou, AC	1
Koutsoukou, AD	1
Losada, I	1
Rita, M	1
Freire, M	1
Graña, G	1
Millán Rodríguez, F	1
Rousaud Barón, F	1
Rousaud Barón, A	1
Dejaco, C	1
Harrer, M	1
Waldhoer, T	1
Miehsler, W	1
Vogelsang, H	1
Reinisch, W	1
Mimura, T	1
Rizzello, F	1
Helwig, U	1
Poggioli, G	1
Schreiber, S	1
Talbot, IC	1
Nicholls, RJ	1
Gionchetti, P	1
Campieri, M	1
Kamm, MA	1
O'Mahony, C	1
Elks, R	1
García Serrano, JL	1
Domínguez, I	1
Serrano Laborda, D	1
Böhringer, R	1
Krautmacher, C	1
Vetter, H	1
Weisser, B	1
Schultz, M	1
Timmer, A	1
Herfarth, HH	1
Sartor, RB	1
Vanderhoof, JA	1
Rath, HC	1
Ikeuchi, H	1
Nakano, H	1
Uchino, M	1
Nakamura, M	1
Yanagi, H	1
Noda, M	1
Yamamura, T	1
Dignass, AU	1
Herrlinger, K	1
Schölmerich, J	1
Baker, SD	1
Horger, DC	1
Keane, TE	1
Naija, W	1
Matéo, J	1
Raskine, L	1
Timsit, JF	1
Lukascewicz, AC	1
George, B	1
Payen, D	1
Mebazaa, A	1
Kumar, VV	1
Gaughan, J	1
Isaacson, G	1
Szeremeta, W	1
Dughera, L	1
Serra, AM	1
Battaglia, E	1
Tibaudi, D	1
Navino, M	1
Emanuelli, G	1
Brzezinski, A	1
Fazio, VW	1
Remzi, FH	1
Achkar, JP	1
Sherman, K	1
Lashner, BA	1
Al Dahouk, S	1
Hagen, RM	1
Nockler, K	1
Tomaso, H	1
Wittig, M	1
Scholz, HC	1
Vergnaud, G	1
Neubauer, H	1
Jean, SS	1
Lee, YT	1
Guo, SM	1
Hsueh, PR	1
Elliott, PR	1
Moore, GT	1
Bell, SJ	1
Connell, WR	1
Heym, B	1
Jouve, F	1
Lemoal, M	1
Veil-Picard, A	1
Lortat-Jacob, A	1
Nicolas-Chanoine, MH	1
Klinge, LG	1
Kjeldsen, J	1
Altay, M	1
Kanbay, M	1
Kurultak, I	1
Altay, FA	1
Aydogan, T	1
Akcay, A	1
Duranay, M	1
Giles, W	1
Dohar, J	1
Iverson, K	1
Cockrum, P	1
Hill, F	1
Hill, N	1
Sanal, O	1
Turkkani, G	1
Gumruk, F	1
Yel, L	1
Secmeer, G	1
Tezcan, I	1
Kara, A	1
Ersoy, F	1
Trinchieri, A	1
Leone, S	1
Fiore, M	1
Felaco, FM	1
Esposito, S	1
Vogel, Y	1
Tannapfel, A	1
Rabsch, W	1
Henning, B	1
Raina, A	1
Kiss, L	1
Yadav, D	1
Daniel, E	1
Brand, ME	1
Trauner, M	1
Grasmug, E	1
Stauber, RE	1
Hammer, HF	1
Hoefler, G	1
Reisinger, EC	1
Risi, GF	1
Pombo, DJ	1
Nielsen, PE	1
Thelle, T	1
Tvede, M	1
Iravani, A	1
Tice, AD	1
McCarty, J	1
Sikes, DH	1
Nolen, T	1
Gallis, HA	1
Whalen, EP	1
Tosiello, RL	1
Heyd, A	2
Kowalsky, SF	1
Wright, PW	1
Wallace, RJ	1
Steingrube, VA	1
Gibson, JL	1
Barth, SS	1
Savitskaia, KI	1
Trapeznikova, MF	1
Nekhorosheva, AG	1
Solodilova, OE	1
Nasonov, VN	1
Dutov, VV	1
Kalinin, VN	1
Shanina, AG	1
Rusanova, EV	1
Pasadakis, P	1
Thodis, E	1
Eftimimiadou, A	1
Panagoutsos, S	1
Papazoglou, D	1
Kaliengidou, M	1
Kartali, S	1
Vargemezis, V	1
Vickers, MH	1
Price, T	1
Pfau, A	1
Sacks, TG	1
Funke, G	1
Nemes, P	1
Lüthy-Hottenstein, J	1
Altwegg, M	1
Mathai, D	1
Kudva, GC	1
Keystone, JS	1
Kozarsky, PE	1
Jesudason, MV	1
Lalitha, MK	1
Kaur, A	1
Thomas, M	1
John, J	1
Pulimood, BM	1
Sheth, KJ	1
Henrickson, KJ	1
Dutta, P	1
Rasaily, R	1
Saha, MR	1
Mitra, U	1
Bhattacharya, SK	1
Bhattacharya, MK	1
Lahiri, M	1
Nelwan, RH	1
Zulkarnain, I	1
Gunawan, J	1
Supandiman, I	1
Yusuf, H	1
Soedjana, P	1
Syahroni, A	1
Cornelissen, JJ	1
Rozenberg-Arska, M	1
Dekker, AW	1
Toth, EL	1
Boychuk, LR	1
Kirkland, PA	1
Marmorale, A	1
Mainguene, C	1
Gavelli, A	1
Huguet, C	1
Roquer, J	1
Cano, A	1
Seoane, JL	1
Pou Serradell, A	1
Melekos, MD	1
Asbach, HW	1
Gerharz, E	1
Zarakovitis, IE	1
Weingaertner, K	1
Naber, KG	1
Wintermeyer, SM	1
Hart, MC	1
Nahata, MC	1
Eltringham, IJ	1
Thalange, N	1
Irish, D	1
Issler, H	1
Teall, A	1
Ireland, D	1
Gehanno, P	1
Kristinsson, JK	1
Hannesson, OB	1
Sveinsson, O	1
Thorleifsson, H	1
Bauwens, JE	1
McFarland, LV	1
Melcher, SA	1
Grossman, R	1
Mukherjee, J	1
Vaughan, D	1
Eastwood, C	1
Cook, R	1
LaForge, J	1
Lampron, N	1
Carlens, S	1
Ringdén, O	1
Aschan, J	1
Hägglund, H	1
Ljungman, P	1
Mattsson, J	1
Remberger, M	1
Jiang, S	1
Wang, X	1
Feng, S	1
Lalonde, RG	1
Barkun, J	1
Caron, F	1
Abril, V	1
Ortega, E	1
Segarra, P	1
Fraile, T	1
Clifford, K	1
Huck, W	1
Shan, M	1
Tosiello, R	1
Echols, RM	1
Casado, JL	1
Valdezate, S	1
Calderon, C	1
Navas, E	1
Frutos, B	1
Guerrero, A	1
Martinez-Beltran, J	1
Donati, L	1
Quadri, P	1
Reiner, M	1
Wakefield, D	1
McCluskey, P	1
Verma, M	1
Aziz, K	1
Gatus, B	1
Carr, G	1
Eickhoff, JH	1
Frimodt-Møller, N	1
Walter, S	1
Frimodt-Møller, C	1
Combemale, P	1
Faisant, M	1
Azoulay-Petit, C	1
Dupin, M	1
Kanitakis, J	1
Verdier, RI	1
Fitzgerald, DW	1
Johnson, WD	1
Pape, JW	1
Roberge, RJ	1
Kaplan, R	1
Frank, R	1
Fore, C	1
Bhowmik, D	1
Dash, SC	1
Dinda, AK	1
Tiwari, SC	1
Agarwal, SK	1
Gupta, S	1
Mathur, RP	1
Butkevich, OM	1
Vinogradova, TL	1
Duch, JM	1
Yee, J	1
Dragsted, UB	1
Pedersen, P	1
Hung, CC	1
Hsieh, SM	1
Hsiao, CF	1
Chen, MY	1
Sheng, WH	1
Gaillat, J	1
Marteau, P	1
Seksik, P	1
Richard, GA	1
Mathew, CP	1
Kirstein, JM	1
Orchard, D	1
Yang, JY	1
Banky, JP	1
Spelman, D	1
Cox, CE	1
Panigrahi, H	1
Cartmill, TD	1
Eisele, G	1
Bailie, GR	1
Lomaestro, B	1
Nathwani, D	1
Wood, MJ	1
Nelson, MR	1
Shanson, DC	1
Hawkins, DA	1
Gazzard, BG	1
Bailey, RR	1
Lynn, KL	1
Robson, RA	1
Peddie, BA	1
Smith, A	1
al-Sibai, MB	1
Halim, MA	1
el-Shaker, MM	1
Khan, BA	1
Qadri, SM	1
Labenz, J	1
Gyenes, E	1
Peitz, U	1
Börsch, G	1
Sacher, HL	1
Miller, WC	1
Landau, SW	1
Sacher, ML	1
Dixon, WA	1
Dietrich, KA	1
Fang, GD	1
Brennen, C	1
Wagener, M	1
Swanson, D	1
Hilf, M	1
Zadecky, L	1
DeVine, J	1
Yu, VL	2
Lang, R	1
Raz, R	2
Sacks, T	1
Shapiro, M	1
Coovadia, Y	1
Seebaran, A	1
Bhana, R	1
Read, RC	1
Barry, RE	1
Pedro-Botet Montoya, J	1
Tomás Vecina, S	1
Soriano Giménez, JC	1
Rubiés-Prat, J	1
Peters, B	1
Pinching, AJ	1
Rubin, J	1
Stoehr, G	1
Muder, RR	1
Matador, A	1
Kamerer, DB	1
Peloquin, CA	1
Cumbo, TJ	1
Nix, DE	1
Sands, MF	1
Schentag, JJ	1
Canton, P	1
Hoen, B	1
Richet, H	1
Ravoire, S	1
Acar, JF	1
Rottensterich, E	1
Hefter, H	1
Kennes, Y	1
Potasman, I	1
Nord, CE	1
Edlund, C	1
Jacobson, MA	1
Hahn, SM	1
Gerberding, JL	1
Lee, B	1
Sande, MA	1
Brutel de la Rivière, T	1
Daniëls-Bosman, MS	1
ten Velde, GP	1
Lonka, L	1
Pedersen, RS	1
Morrison, GA	1
Bailey, CM	1
Meisel, C	1
Blenk, H	1
Ehlers, S	1
Hahn, H	1
Vellucci, A	1
De Rosa, F	1
Bernardini, G	1
Di Vico, B	1
Connolly, MJ	1
Snow, MH	1
Ingham, HR	1
Garlando, F	1
Rietiker, S	1
Täuber, MG	1
Flepp, M	1
Meier, B	1
Lüthy, R	1
Fass, RJ	1
Greenberg, RN	1
Kennedy, DJ	1
Reilly, PM	1
Luppen, KL	1
Weinandt, WJ	1
Bollinger, MR	1
Aguirre, F	1
Kodesch, F	1
Saeed, AM	1
Bryant, RE	1
Hartstein, AI	1
Brown, EM	1
Morris, R	1
Stephenson, TP	1